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Identity 
Note: The 3 translocations are variants of each other, and they share the same clinical significance. 
 
Left, from top to bottom: t(2;18)(p11;q21), t(14;18)(q32;q21), t(18;22)(q21;q11), G-banding - Courtesy Jean-Luc Lai and Alain 
Vanderhaegen; and, right: t(14;18)(q32;q21), R-banding - Editor. 
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Clinics and pathology 
Disease 
B-cell NHL mainly; may (rarely) be found in ALL or in 
chronic lymphoproliferative diseases. 
Phenotype / cell stem origin 
B lymphocyte; the translocation occurs at the pre B cell 
stage. 
Epidemiology 
Found in 80 to 90% of follicular lymphomas, 30% of 
diffuse large cell lymphomas (sometimes with prior 
follicular type), rarely in other lymphoproliferative 
disorders. 
Prognosis 
Small cleaved cell follicular lymphomas have a slow 
evolutivity and a median survival of 10 yrs or more; 
large cell lymphomas have a worse prognosis; the 
t(14;18) may have little or no prognostic significan e, 





BAC248E24 (BCL2, 18q21, green) cohybridized with PAC 
PAC 998D24 (14q32.3, red, centromeric to the breakpoint) - 
Courtesy Mariano Rocchi, Resources for Molecular 
Cytogenetics. 
Cytogenetics, morphological 
The t(14;18) is well recognized with G-banding, may 
be overlocked with R-banding; the t(2;18)(p11;q21) 
and the t(18;22)(q21;q11) are rare variants. 
Additional anomalies 
Found in 90% of cases; complex karyotypes are 
frequent; by decreasing order, +7, del(6q), +12, +X, 
+18, +5, +8, +der(18), +21 are found in 25 to 10% of 
cases; +X and del(6q) more frequently in low grade, 
+7, +8, +der(18), and also the addition of a 
t(8;14)(q24;q32) more often in high grade NHL. 
Genes involved and Proteins 
IgH 
Location: 14q32 
DNA / RNA 
IGH is composed of IGHV genes, IGHD segments, 
IGHJ segments, and IGHC genes. 
Protein 
IGH encodes the immunoglobulin heavy chains. They 
result from the DNA rearrangement (with deletion of 
the intermediary DNA) of IGHV, IGHD and IGHJ; an 
additional DNA rearrangement (switch) with constant 
genes IGHM → IGHG, IGHA and IGHE can occur. 
BCL2 
Location: 18q21 
DNA / RNA 
3 exons; 2 alternative transcripts (a and b). 
Protein 
Member of the BCL2 family (with BAX, BCLX,...); 
contains dimerization domains (BH) and NH domains; 
BCL2a contains a hydrophobic tail for membrane 
anchorage; inhibits cell death process through 
heterodimerization. 




5' BCL2 translocated on chromosome 14 near JH 
(junctions genes of IgH) and C in 3'; the breakpoint in 
BCL2 is either in the 3' untranslated region of exon 3 
(major breakpoint region (MBR) in 70% of cases) or 
more distal, in 3' of exon 3 (minor cluster region 




No fusion protein, but promoter exchange; the 
immunoglobulin gene enhancer stimulates the 
expression of BCL2. 
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Oncogenesis 
As BCL2 is an apoptosis inhibitor, cell death is 
delayed, and there is cell accumulation more than re l 
transformation (clones of long living B-cells with 
t(14;18) may even be seen in the normal population, 
and with frequency increasing with age). 
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